Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dicalcium phosphate is an inorganic calcium salt (CaHPO4) that serves multiple roles in medicine, dentistry, and nutrition. In the pharmaceutical industry, it is a widely used excipient, functioning as a brittle filler or diluent in direct compression tableting. In dentistry, it is utilized in formulations for enamel remineralization and the treatment of dentin hypersensitivity, where it acts as a source of calcium and phosphate ions to facilitate the formation of hydroxyapatite. Its hydrated form, brushite (DCPD), and anhydrous form, monetite, are employed as resorbable bone graft substitutes in orthopedic and alveolar bone regeneration procedures. Furthermore, it is a common dietary supplement used to address mineral deficiencies in both human and veterinary medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dicalcium phosphate.